MYCN and neuroblastoma: The presence of either a chromosome 1p deletion, and/or a chromosome 11q deletion, and/or a 17q gain was associated with poorer OS according to a multivariate survival analysis, suggesting that these particular mutations are important for patients with MYCN non-amplified neuroblastomas [37].